4DD-16746-31713

3 vaccinations 12 coded responses 39 check-ins 12 free-text entries 2 call cases

Sex: Male
Age at first dose: 36-40
ZIP prefix: 448 / OH
Registered: 2021-03-04

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Registered in v-safe
2021-03-04
Dose 1 — Pfizer-BioNTech
2021-03-04
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-03-05
Survey response — days 1–6 daily, dose 1
MedDRA: Disturbance in attention — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Free text: Difficulty focusing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain

Adult check-in
2021-03-11
Health check-in — day 7, dose 1
Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain

Adult check-in
2021-03-18
Survey response — day 14, dose 1
MedDRA: Cough, Dizziness, Nausea — Feeling: Poor

Free text: Cough, nausea, dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Dose 2 — Pfizer-BioNTech
2021-03-25
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-03-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-01
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-08
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-15
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-22
Survey response — day 28, dose 2
MedDRA: Diarrhoea, Headache, Nausea — Feeling: Fair

Free text: Nausea, headache, diarrhea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-29
Survey response — day 35, dose 2
MedDRA: Dizziness, Nausea, Pyrexia — Feeling: Poor · Be unable to do your normal daily activities

Free text: Nausea, dizziness, fever

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Survey response — day 42, dose 2
MedDRA: Diarrhoea, Pyrexia, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Vomiting, diarrhea, fever

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-24
Survey response — 3 months, dose 2
MedDRA: Cough, Diarrhoea, Nausea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Coughing, nausea and diarrhea that lasted for 2 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-23
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-05
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2021-10-05
Health check-in — day 0, dose 3
Feeling: Good · Site: Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-10-08
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain

Adult check-in
2021-10-10
Survey response — days 1–6 daily, dose 3
MedDRA: Back pain — Feeling: Good · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain

Free text: Lower back pain

MedDRA releases: 2024-11 · check-in free text available
2021-10-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Itching · Headache, Muscle or body aches

Adult check-in
2021-10-12
Health check-in — day 7, dose 3
Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-19
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-26
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-11-02
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-09
Survey response — day 35, dose 3
MedDRA: Cough, Fatigue, Nausea, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cough, congestion, nausea, fatigue

MedDRA releases: 2024-11 · check-in free text available
2021-11-16
Survey response — day 42, dose 3
MedDRA: Chest pain, Chills, Fatigue, Pyrexia, Vomiting — Feeling: Poor · Be unable to work or attend school

Free text: Fever, vomiting, chills, chest pain, fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-01-04
Survey response — 3 months, dose 3
MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school

Free text: COVID-19

MedDRA releases: 2024-11 · check-in free text available
2022-04-05
Survey response — 6 months, dose 3
MedDRA: Diplopia, Hyperglycaemia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Hyperglycemia, monocular diplopia

MedDRA releases: 2024-11 · check-in free text available
2022-04-05
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-12
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-10-05
Survey response — 12 months, dose 3
MedDRA: COVID-19, Neuropathy peripheral, Vestibular neuronitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: I have developed both peripheral and central vestibular neuritis and have gotten sick with COVID a second time.

MedDRA releases: 2024-11 · check-in free text available
2022-10-05
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-10-06
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Pfizer-BioNTech
2	2021-03-25	Pfizer-BioNTech
3	2021-10-05	Pfizer-BioNTech	Flu

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-05

Systemic reaction (other): Difficulty focusing

Release 5 — day 14, dose 1

2021-03-18

Symptoms: Cough, nausea, dizziness

Release 7 — day 28, dose 2

2021-04-22

Symptoms: Nausea, headache, diarrhea

Release 8 — day 35, dose 2

2021-04-29

Symptoms: Nausea, dizziness, fever

Release 8 — day 42, dose 2

2021-05-06

Symptoms: Vomiting, diarrhea, fever

Release 9 — 3 months, dose 2

2021-06-24

Symptoms: Coughing, nausea and diarrhea that lasted for 2 days.

Release 10 — days 1–6 daily, dose 3

2021-10-10

Systemic reaction (other): Lower back pain

Release 10 — day 35, dose 3

2021-11-09

Symptoms: Cough, congestion, nausea, fatigue

Release 10 — day 42, dose 3

2021-11-16

Symptoms: Fever, vomiting, chills, chest pain, fatigue

Release 10 — 3 months, dose 3

2022-01-04

Symptoms: COVID-19

Release 11 — 6 months, dose 3

2022-04-05

Symptoms: Hyperglycemia, monocular diplopia

Release 12 — 12 months, dose 3

2022-10-05

Symptoms: I have developed both peripheral and central vestibular neuritis and have gotten sick with COVID a second time.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chest pain	·	·	✓
SD	Chills	·	·	✓
SD	Cough	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Diarrhoea	✓	✓	✓
SD	Diplopia	·	·	✓
SD	Dizziness	✓	✓	✓
SD	Fatigue	·	·	✓
SD	Headache	✓	✓	✓
SD	Hyperglycaemia	·	·	✓
SD	Nausea	✓	✓	✓
SD	Neuropathy peripheral	·	·	✓
SD	Pyrexia	✓	✓	✓
SD	Respiratory tract congestion	·	·	✓
SD	Vestibular neuronitis	·	·	✓
SD	Vomiting	✓	✓	✓
SRO	Back pain	·	·	✓
SRO	Disturbance in attention	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release